Dr. Hönle AG reported earnings results for the second quarter and six months ended March 31, 2025. For the second quarter, the company reported sales was EUR 25.76 million compared to EUR 24.34 million a year ago. Net income was EUR 0.194 million compared to EUR 0.181 million a year ago.
For the six months, sales was EUR 47.17 million compared to EUR 48.12 million a year ago. Net loss was EUR 0.399 million compared to EUR 0.729 million a year ago. Basic loss per share from continuing operations was EUR 0.07 compared to EUR 0.13 a year ago. Diluted loss per share from continuing operations was EUR 0.07 compared to EUR 0.13 a year ago.